patient

INQOVI® (previously known as ASTX727) is a prescribed oral tablet combination of decitabine and cedazuridine approved by the Food and Drug Administration for adult patients with myelodysplastic syndromes (MDS) and…

FABHALTA, a complement factor B inhibitor, is the first oral medication approved to treat adults with paroxysmal nocturnal hemoglobinuria (PNH)

Form to keep track of platelet transfusions as part of MDS treatment

Form to keep track of blood transfusions as part of MDS treatment

Chart to record medical professionals, pharmacy contacts, patient support organizations and others involved with your health care

Form to record symptoms or reactions to treatment and medications that can be shared with health care providers

Form to record health care visits and notes

Use the AAMDS Map of Specialists to find an MDS expert

Guidelines for managing your MDS treatment plan with your health care team

Guidelines and suggested questions for making the most of your health care appointments